🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
66.89
-1.71 (-2.49%)
At close: Nov 20, 2026, 4:00 PM EST
67.48
+0.59 (0.89%)
After-hours: Nov 20, 2026, 7:30 PM EST

Globus Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
557.64537.87102.98122.87190.17149.19
Depreciation & Amortization
279.22276.84253.39145.5368.2569.87
Loss (Gain) From Sale of Assets
10.8512.535.551.540.30.46
Asset Writedown & Restructuring Costs
--12.61-0.1534.31
Loss (Gain) From Sale of Investments
----5.392.78
Stock-Based Compensation
49.1649.7854.1952.7432.8130.59
Provision & Write-off of Bad Debts
18.8710.2216.993.66-01.2
Other Operating Activities
91.47-67172.4833.76-13.345.13
Change in Accounts Receivable
-76.5-52.18-78.06-49.91-50.84-25.9
Change in Inventory
-60.26-17.6-29.86-70.33-61.75-11.97
Change in Accounts Payable
15.818.4917.66-14.2214.423.68
Change in Income Taxes
24.63-50.85-13.38-0.41-2.895.21
Change in Other Net Operating Assets
15.0545.356.0818.28-4.2111.72
Operating Cash Flow
925.92753.45520.64243.5178.47276.27
Operating Cash Flow Growth
29.46%44.72%113.81%36.44%-35.40%38.98%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-159.37-164.68-115.43-78.27-74.05-56.9
Cash Acquisitions
-12.75-252.55-17.64-296.03-31.44-34.49
Sale (Purchase) of Intangibles
-9.75-9.75----
Investment in Securities
-397.2171.96-42.99677.27-4.88-284.55
Investing Cash Flow
-579.07-355.01-176.05302.97-110.36-375.94

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--449.99----
Net Debt Issued (Repaid)
--449.99----
Issuance of Common Stock
115.5789.76110.4412.441.7263.5
Repurchase of Common Stock
-327.67-303.36-92.52-236.18-144.49-
Other Financing Activities
-21.75-15.57-45.62-8.04-7.19-9.35
Financing Cash Flow
-233.84-679.16-27.7-231.82-109.9654.15

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
2.9222.450.262.18-0.75-0.81
Net Cash Flow
115.92-258.28317.15316.83-42.6-46.33

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
766.55588.77405.21165.23104.42219.38
Free Cash Flow Growth
32.25%45.30%145.25%58.23%-52.40%62.34%
Free Cash Flow Margin
24.41%20.03%16.08%10.53%10.21%22.90%
Free Cash Flow Per Share
5.594.302.941.441.022.12
Levered Free Cash Flow
509.87327.53597.73-346.1375.52160.53
Unlevered Free Cash Flow
509.87327.53600.35-346.1375.52160.53

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
69.6298.92158.51100.5977.8245.03
Change in Working Capital
-81.29-66.8-97.55-116.6-105.26-17.25
SEC Filings: 10-K · 10-Q